Suppr超能文献

COPD 患者的医疗保健使用史、GOLD 指南和呼吸药物处方。

Health care utilization history, GOLD guidelines, and respiratory medication prescriptions in patients with COPD.

机构信息

Pulmonary, Critical Care, and Sleep Division, Cincinnati Veterans Affairs Medical Center, Cincinnati, OH, USA.

出版信息

Int J Chron Obstruct Pulmon Dis. 2010 Apr 7;5:89-97. doi: 10.2147/copd.s8822.

Abstract

BACKGROUND

The relationship between prior health care utilization and respiratory medication prescriptions in an unselected population of patients with COPD is not known.

METHODS

We determined the prescribed respiratory medications and respiratory and nonrespiratory health care encounters in 523 Veterans with COPD at the Cincinnati Veterans Affairs Medical Center between 2000 and 2005. Prescribed treatments were compared with the GOLD guidelines and each patient was classified as receiving less medications than recommended in the guidelines (<G), medications according to the guidelines (=G), or more medications than recommended (>G).

RESULTS

Respiratory medications were <G for 54%, =G in 33%, and >G for 14% of the patients studied. For GOLD stages 1 and 2, G patients the most prior respiratory encounters during a 12 month period (0.31 +/- 0.073 (0.21, 0.47), 0.75 +/- 0.5 (0.37, 1.5), 1.1 +/- 0.27 (0.74, 1.6) visits/person/year, <G, =G, >G, respectively, mean + standard error of mean (SEM) (95% confidence limits) 2 degrees of freedom (df) ANOVA P < 0.001 for prescription effect). For GOLD stages 3 and 4, <G was associated with significantly fewer prior respiratory visits than was =G (0.78 +/- 0.11 (0.6, 1.0) and 2.4 +/- 0.47 (1.9, 3.1) visits/person/year, respectively, P < 0.001). There were no differences in nonrespiratory health care visits for GOLD stages 1 and 2 by prescription level (3.1 +/- 0.24 (2.6, 3.5), 3.1 +/- 0.46 (2.1, 4.6) and 4.1 +/- 0.55 (3.3, 5.1) visits/person/year, <G, =G, >G respectively, 2 df ANOVA P = 0.096) or for GOLD stages 3 and 4 (3.6 +/- 0.25 (3.2, 4.1) and 4.0 +/- 0.44 (3.3, 4.9) visits/person/year, <G and =G, respectively, P = 0.36).

CONCLUSIONS

Respiratory medications prescribed for an unselected population with a broad range of COPD severity complied poorly with the GOLD pharmacologic treatment guidelines but correlated with the number of prior respiratory health care visits.

摘要

背景

在未选择的 COPD 患者人群中,先前的医疗保健利用与呼吸药物处方之间的关系尚不清楚。

方法

我们确定了 2000 年至 2005 年间辛辛那提退伍军人事务医疗中心的 523 名 COPD 退伍军人的处方呼吸药物和呼吸及非呼吸保健就诊情况。将所开处方的治疗药物与 GOLD 指南进行了比较,并且将每位患者分为以下三种情况:推荐药物用量以下(<G)、推荐药物用量(=G)或推荐药物用量以上(>G)。

结果

研究中,<G、=G 和 >G 患者分别占 54%、33%和 14%。对于 GOLD 1 期和 2 期,<G 患者在 12 个月内的呼吸就诊次数最少,而 >G 患者的呼吸就诊次数最多(0.31 +/- 0.073(0.21, 0.47)、0.75 +/- 0.5(0.37, 1.5)、1.1 +/- 0.27(0.74, 1.6)次/人/年,<G、=G、>G,分别为平均值+标准误差(SEM)(95%置信区间),2 自由度(df)ANOVA P < 0.001 用于处方效应)。对于 GOLD 3 期和 4 期,与 =G 相比,<G 与显著较少的先前呼吸就诊相关(0.78 +/- 0.11(0.6, 1.0)和 2.4 +/- 0.47(1.9, 3.1)次/人/年,P < 0.001)。GOLD 1 期和 2 期的非呼吸保健就诊次数,按处方水平无差异(3.1 +/- 0.24(2.6, 3.5)、3.1 +/- 0.46(2.1, 4.6)和 4.1 +/- 0.55(3.3, 5.1)次/人/年,<G、=G、>G,2 df ANOVA P = 0.096),或 GOLD 3 期和 4 期(3.6 +/- 0.25(3.2, 4.1)和 4.0 +/- 0.44(3.3, 4.9)次/人/年,<G 和 =G,P = 0.36)。

结论

为具有广泛 COPD 严重程度的未选择人群开具的呼吸药物处方与 GOLD 药理学治疗指南不符,但与先前的呼吸保健就诊次数相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/384f/2865029/a47c335c868b/copd-5-089f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验